Exact Sciences
EXAS
Performance
About Exact Sciences
Exact Sciences is a cancer diagnostics company focused on prevention, early detection, and therapy guidance. The company develops and provides diagnostic tests that assess hereditary risks, screen for cancer presence, and analyze genomic alterations to guide treatment, serving patients, providers, researchers, and healthcare systems. Headquartered in Madison, Wisconsin, Exact Sciences collaborates with laboratories, institutions, and policy makers to advance cancer care globally.
Recent News
Compass Therapeutics, Inc. (CMPX) Up 200% Year-on-Year
Clio Health Champions 2025: Meet 20 Leaders Driving Progress in Healthcare Marketing
Is Pharma Missing the Boat on Diagnostics?
Toward Equitable Access to Cell and Gene Therapies: Rethinking Co-Payments
KeyCare Secures $27.4M Funding Round
Abbott Launches New Cardiovascular Diagnostics and Wearables, Expanding Digital Health Portfolio
KeyCare Raises $27.4 Million To Scale AI-Enabled Virtual Care
Labcorp Expands Epic Pact to Make Full Test Menu Available on Aura
Alphabet Boosts Portfolio Value by $1.5 B, Adds CME Group as Top Holding
Abbott Beats Q1 Sales, Raises FY26 Outlook After Exact Sciences Deal
#58773
Abbott Lowers Earnings Forecast After $21B Exact Sciences Buy